Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

44 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Ductal Adenocarcinoma trial results

Recruiting

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

NCT07490301

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Locations
  • City Of Hope - Chicago /ID# 279814 Zion, Illinois, United States
  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279853 Grand Rapids, Michigan, United States
  • Texas Oncology - Northeast Texas /ID# 280417 Tyler, Texas, United States
  • Virginia Cancer Specialists - Fairfax /ID# 280415 Fairfax, Virginia, United States
View all 19 locations
View Trial Details
Recruiting

Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations

NCT07640295

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
  • Beijing Tsinghua Changgung Hospital Beijing, China
  • Hunan Cancer Hospital Changsha, China
View all 13 locations
View Trial Details
Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT06989437

Conditions
Anorexia, Body Weight, Body Weight Changes, +19 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Central Arkansas Radiation Therapy Institute, dba CARTI Bryant, Arkansas, United States
View all 220 locations
View Trial Details
Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

NCT07165951

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
View all 71 locations
View Trial Details

Related conditions